US Stock MarketDetailed Quotes

Vertex Pharmaceuticals (VRTX)

Watchlist
  • 450.410
  • -2.650-0.58%
Close May 14 15:59 ET
  • 450.400
  • -0.0100.00%
Post 18:11 ET
114.32BMarket Cap26.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals (VRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
7.82%2.99B
8.90%12B
9.55%3.19B
10.99%3.08B
12.06%2.96B
2.96%2.77B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
Operating revenue
8.21%2.99B
8.63%11.97B
9.55%3.19B
10.99%3.08B
11.28%2.94B
2.59%2.76B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
Cost of revenue
8.21%392.8M
7.89%1.65B
10.06%466M
5.65%414.8M
9.57%407.5M
5.95%363M
21.26%1.53B
15.05%423.4M
23.19%392.6M
20.51%371.9M
Gross profit
7.76%2.59B
9.07%10.35B
9.46%2.72B
11.86%2.66B
12.47%2.56B
2.52%2.41B
10.25%9.49B
15.76%2.49B
9.91%2.38B
4.08%2.27B
Operating expense
5.76%1.46B
-40.39%5.8B
-73.46%1.59B
14.03%1.42B
4.80%1.4B
21.59%1.38B
101.45%9.72B
248.95%6B
16.19%1.25B
27.71%1.34B
Selling and administrative expenses
24.55%493.7M
19.72%1.75B
28.97%487M
19.71%445.1M
14.08%424.6M
15.67%396.4M
28.83%1.46B
2.30%377.6M
40.94%371.8M
41.74%372.2M
Research and development costs
-1.85%961.6M
-51.05%4.04B
-80.33%1.11B
11.62%977.7M
1.22%978.4M
24.15%979.7M
123.81%8.26B
316.30%5.63B
8.14%875.9M
23.02%966.6M
Operating profit
10.45%1.14B
2,051.33%4.55B
132.15%1.13B
9.47%1.24B
23.46%1.15B
-15.22%1.03B
-106.17%-233.4M
-919.79%-3.52B
3.72%1.13B
-17.72%934.9M
Net non-operating interest income expense
-2.63%114.8M
-15.84%477.6M
-5.42%118.6M
-1.84%122.4M
-19.03%118.7M
-30.97%117.9M
-0.54%567.5M
-25.75%125.4M
-20.57%124.7M
9.81%146.6M
Non-operating interest income
-2.63%114.8M
-17.92%490.9M
-4.91%121.9M
-4.92%125.7M
-21.79%122.4M
-34.93%117.9M
-2.70%598.1M
-28.58%128.2M
-21.26%132.2M
8.15%156.5M
Non-operating interest expense
----
-56.54%13.3M
17.86%3.3M
-56.00%3.3M
-62.63%3.7M
-71.15%3M
-30.61%30.6M
-73.58%2.8M
-31.19%7.5M
-11.61%9.9M
Other net income (expense)
99.83%-700K
-354.21%-388.8M
-98.19%82.1M
-93.79%-62.4M
100.23%10.1M
-287.95%-418.6M
-397.22%-85.6M
723.43%4.53B
53.20%-32.2M
-4,029.92%-4.47B
Special income (charges)
99.83%-700K
-76,320.00%-381.1M
-98.34%75.6M
-243.79%-52.6M
99.93%-3.1M
-422.82%-401M
-99.03%500K
711.67%4.54B
71.08%-15.3M
-3,948.77%-4.45B
-Less：Restructuring and merger&acquisition
-90.91%200K
520.00%2.1M
175.00%900K
-733.33%-1.9M
80.00%900K
2,300.00%2.2M
99.03%-500K
97.61%-1.2M
-75.00%300K
183.33%500K
-Less:Impairment of capital assets
--0
--379M
--0
--0
--0
--379M
--0
--0
--0
--0
-Less:Other special charges
-97.47%500K
----
----
263.33%54.5M
-99.95%2.2M
-74.22%19.8M
778.09%4.63B
391.57%87.5M
-70.99%15M
3,926.33%4.45B
Other non- operating income (expenses)
----
91.06%-7.7M
143.62%6.5M
42.01%-9.8M
157.14%13.2M
43.59%-17.6M
-277.63%-86.1M
-52.04%-14.9M
-6.29%-16.9M
-1,543.75%-23.1M
Income before tax
71.54%1.25B
1,768.49%4.64B
17.11%1.33B
6.10%1.3B
137.83%1.28B
-42.90%730.4M
-94.33%248.5M
-0.97%1.14B
3.81%1.22B
-391.97%-3.39B
Income tax
163.38%221.5M
-12.00%690M
-37.40%139.9M
20.82%215.9M
23.57%250.1M
-53.15%84.1M
3.14%784.1M
25.00%223.5M
24.18%178.7M
-17.66%202.4M
Net income
59.59%1.03B
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
Net income continuous Operations
59.59%1.03B
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
Minority interest income
Net income attributable to the parent company
59.59%1.03B
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
59.59%1.03B
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
Basic earnings per share
61.11%4.06
843.27%15.46
32.11%4.69
4.69%4.24
128.88%4.02
-40.85%2.52
-114.80%-2.08
-5.59%3.55
1.00%4.05
-492.11%-13.92
Diluted earnings per share
61.45%4.02
836.54%15.32
32.86%4.65
4.74%4.2
128.66%3.99
-40.86%2.49
-114.97%-2.08
-5.66%3.5
1.01%4.01
-495.45%-13.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 7.82%2.99B8.90%12B9.55%3.19B10.99%3.08B12.06%2.96B2.96%2.77B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B
Operating revenue 8.21%2.99B8.63%11.97B9.55%3.19B10.99%3.08B11.28%2.94B2.59%2.76B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B
Cost of revenue 8.21%392.8M7.89%1.65B10.06%466M5.65%414.8M9.57%407.5M5.95%363M21.26%1.53B15.05%423.4M23.19%392.6M20.51%371.9M
Gross profit 7.76%2.59B9.07%10.35B9.46%2.72B11.86%2.66B12.47%2.56B2.52%2.41B10.25%9.49B15.76%2.49B9.91%2.38B4.08%2.27B
Operating expense 5.76%1.46B-40.39%5.8B-73.46%1.59B14.03%1.42B4.80%1.4B21.59%1.38B101.45%9.72B248.95%6B16.19%1.25B27.71%1.34B
Selling and administrative expenses 24.55%493.7M19.72%1.75B28.97%487M19.71%445.1M14.08%424.6M15.67%396.4M28.83%1.46B2.30%377.6M40.94%371.8M41.74%372.2M
Research and development costs -1.85%961.6M-51.05%4.04B-80.33%1.11B11.62%977.7M1.22%978.4M24.15%979.7M123.81%8.26B316.30%5.63B8.14%875.9M23.02%966.6M
Operating profit 10.45%1.14B2,051.33%4.55B132.15%1.13B9.47%1.24B23.46%1.15B-15.22%1.03B-106.17%-233.4M-919.79%-3.52B3.72%1.13B-17.72%934.9M
Net non-operating interest income expense -2.63%114.8M-15.84%477.6M-5.42%118.6M-1.84%122.4M-19.03%118.7M-30.97%117.9M-0.54%567.5M-25.75%125.4M-20.57%124.7M9.81%146.6M
Non-operating interest income -2.63%114.8M-17.92%490.9M-4.91%121.9M-4.92%125.7M-21.79%122.4M-34.93%117.9M-2.70%598.1M-28.58%128.2M-21.26%132.2M8.15%156.5M
Non-operating interest expense -----56.54%13.3M17.86%3.3M-56.00%3.3M-62.63%3.7M-71.15%3M-30.61%30.6M-73.58%2.8M-31.19%7.5M-11.61%9.9M
Other net income (expense) 99.83%-700K-354.21%-388.8M-98.19%82.1M-93.79%-62.4M100.23%10.1M-287.95%-418.6M-397.22%-85.6M723.43%4.53B53.20%-32.2M-4,029.92%-4.47B
Special income (charges) 99.83%-700K-76,320.00%-381.1M-98.34%75.6M-243.79%-52.6M99.93%-3.1M-422.82%-401M-99.03%500K711.67%4.54B71.08%-15.3M-3,948.77%-4.45B
-Less：Restructuring and merger&acquisition -90.91%200K520.00%2.1M175.00%900K-733.33%-1.9M80.00%900K2,300.00%2.2M99.03%-500K97.61%-1.2M-75.00%300K183.33%500K
-Less:Impairment of capital assets --0--379M--0--0--0--379M--0--0--0--0
-Less:Other special charges -97.47%500K--------263.33%54.5M-99.95%2.2M-74.22%19.8M778.09%4.63B391.57%87.5M-70.99%15M3,926.33%4.45B
Other non- operating income (expenses) ----91.06%-7.7M143.62%6.5M42.01%-9.8M157.14%13.2M43.59%-17.6M-277.63%-86.1M-52.04%-14.9M-6.29%-16.9M-1,543.75%-23.1M
Income before tax 71.54%1.25B1,768.49%4.64B17.11%1.33B6.10%1.3B137.83%1.28B-42.90%730.4M-94.33%248.5M-0.97%1.14B3.81%1.22B-391.97%-3.39B
Income tax 163.38%221.5M-12.00%690M-37.40%139.9M20.82%215.9M23.57%250.1M-53.15%84.1M3.14%784.1M25.00%223.5M24.18%178.7M-17.66%202.4M
Net income 59.59%1.03B838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B
Net income continuous Operations 59.59%1.03B838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B
Minority interest income
Net income attributable to the parent company 59.59%1.03B838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 59.59%1.03B838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B
Basic earnings per share 61.11%4.06843.27%15.4632.11%4.694.69%4.24128.88%4.02-40.85%2.52-114.80%-2.08-5.59%3.551.00%4.05-492.11%-13.92
Diluted earnings per share 61.45%4.02836.54%15.3232.86%4.654.74%4.2128.66%3.99-40.86%2.49-114.97%-2.08-5.66%3.51.01%4.01-495.45%-13.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -